|
2025-04-14 |
2025-04-11 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
1 000
-0.1%
13,14
631 USD
|
1 000
-0.1%
|
13,14
|
100 000 USD
|
|
|
2025-02-12 |
2025-02-12 |
VP
Vente planifiée
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
5 200
-5.0%
23,53
122 356 USD
|
5 200
-5.0%
|
23,53
|
122 356 USD
|
|
|
2025-02-12 |
2025-02-12 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
8 000
-8.2%
23,53
188 240 USD
|
8 000
-8.2%
|
23,53
|
188 240 USD
|
|
|
2025-02-12 |
2025-02-12 |
V
Vente
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
2 568
-2.0%
23,53
60 426 USD
|
2 568
-2.0%
|
23,53
|
60 426 USD
|
|
|
2025-02-12 |
2025-02-12 |
V
Vente
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
2 568
-2.8%
23,53
60 426 USD
|
2 568
-2.8%
|
23,53
|
60 426 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
9 244
-14.5%
25,00
231 100 USD
|
9 244
-14.5%
|
25,00
|
231 100 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
15 000
-19.1%
25,00
375 000 USD
|
15 000
-19.1%
|
25,00
|
375 000 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
10 000
-13.6%
25,00
250 000 USD
|
10 000
-13.6%
|
25,00
|
250 000 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
10 000
-13.6%
25,00
250 000 USD
|
10 000
-13.6%
|
25,00
|
250 000 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
10 000
-13.6%
25,00
250 000 USD
|
10 000
-13.6%
|
25,00
|
250 000 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
3 074
-2.4%
25,00
76 850 USD
|
3 074
-2.4%
|
25,00
|
76 850 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
11 375
-2.6%
24,04
273 455 USD
|
11 375
-2.6%
|
24,04
|
273 455 USD
|
|
|
2025-02-10 |
2025-02-06 |
VP
Vente planifiée
|
Baynes Roy D.
Administrateur non-exécutif
|
10 000
-24.4%
22,00
220 000 USD
|
10 000
-24.4%
|
22,00
|
220 000 USD
|
|
|
2025-02-04 |
2025-02-04 |
VP
Vente planifiée
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
1 066
-1.3%
20,11
21 437 USD
|
1 066
-1.3%
|
20,11
|
21 437 USD
|
|
|
2025-02-04 |
2025-02-03 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
8 951
-9.1%
19,78
177 051 USD
|
8 951
-9.1%
|
19,78
|
177 051 USD
|
|
|
2025-02-04 |
2025-02-03 |
VP
Vente planifiée
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
50 691
-10.5%
20,21
1 024 343 USD
|
50 691
-10.5%
|
20,21
|
1 024 343 USD
|
|
|
2025-02-04 |
2025-02-03 |
VP
Vente planifiée
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
8 951
-8.6%
19,78
177 051 USD
|
8 951
-8.6%
|
19,78
|
177 051 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Vente
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
3 348
-5.0%
20,12
67 362 USD
|
3 348
-5.0%
|
20,12
|
67 362 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Vente
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
4 207
-4.7%
20,12
84 645 USD
|
4 207
-4.7%
|
20,12
|
84 645 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Vente
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
5 166
-4.0%
20,12
103 940 USD
|
5 166
-4.0%
|
20,12
|
103 940 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
5 192
-5.5%
20,12
104 463 USD
|
5 192
-5.5%
|
20,12
|
104 463 USD
|
|
|
2025-01-23 |
2025-01-23 |
VP
Vente planifiée
|
Baynes Roy D.
Administrateur non-exécutif
|
16 000
-34.0%
20,00
320 000 USD
|
16 000
-34.0%
|
20,00
|
320 000 USD
|
|
|
2025-01-23 |
2025-01-22 |
VP
Vente planifiée
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
2 437
-2.8%
19,46
47 424 USD
|
2 437
-2.8%
|
19,46
|
47 424 USD
|
|
|
2025-01-23 |
2025-01-22 |
VP
Vente planifiée
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
10 736
-3.0%
19,46
208 923 USD
|
10 736
-3.0%
|
19,46
|
208 923 USD
|
|
|
2025-01-23 |
2025-01-22 |
V
Vente
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
925
-1.7%
18,94
17 520 USD
|
925
-1.7%
|
18,94
|
17 520 USD
|
|
|
2025-01-23 |
2025-01-22 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
2 437
-3.1%
19,46
47 424 USD
|
2 437
-3.1%
|
19,46
|
47 424 USD
|
|
|
2025-01-23 |
2025-01-22 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
865
-1.2%
18,94
16 384 USD
|
865
-1.2%
|
18,94
|
16 384 USD
|
|
|
2025-01-23 |
2025-01-22 |
V
Vente
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
1 584
-1.5%
18,94
30 002 USD
|
1 584
-1.5%
|
18,94
|
30 002 USD
|
|
|
2025-01-06 |
2025-01-06 |
VP
Vente planifiée
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
440
-0.7%
18,76
8 254 USD
|
440
-0.7%
|
18,76
|
8 254 USD
|
|
|
2025-01-06 |
2025-01-03 |
V
Vente
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
2 066
-3.3%
19,10
39 461 USD
|
2 066
-3.3%
|
19,10
|
39 461 USD
|
|
|
2024-12-27 |
2024-12-26 |
VP
Vente planifiée
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
15 000
-21.5%
17,22
258 278 USD
|
15 000
-21.5%
|
17,22
|
258 278 USD
|
|
|
2024-11-25 |
2024-11-25 |
V
Vente
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
12 090
-18.0%
18,30
221 258 USD
|
12 090
-18.0%
|
18,30
|
221 258 USD
|
|
|
2024-10-04 |
2024-10-04 |
VP
Vente planifiée
|
LYONS GARY A
Administrateur non-exécutif
|
18 821
-27.0%
15,15
285 227 USD
|
18 821
-27.0%
|
15,15
|
285 227 USD
|
|
|
2024-10-04 |
2024-10-04 |
VP
Vente planifiée
|
LYONS GARY A
Administrateur non-exécutif
|
21 179
-23.3%
14,35
303 874 USD
|
21 179
-23.3%
|
14,35
|
303 874 USD
|
|
|
2024-09-30 |
2024-09-30 |
VP
Vente planifiée
|
Meckler Jeffrey A
Administrateur non-exécutif
|
40 000
-33.1%
14,06
562 324 USD
|
40 000
-33.1%
|
14,06
|
562 324 USD
|
|
|
2024-09-10 |
2024-09-10 |
VP
Vente planifiée
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
684
-1.1%
12,98
8 878 USD
|
684
-1.1%
|
12,98
|
8 878 USD
|
|
|
2024-09-09 |
2024-09-09 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
4 387
-5.3%
11,52
50 538 USD
|
4 387
-5.3%
|
11,52
|
50 538 USD
|
|
|
2024-09-09 |
2024-09-09 |
V
Vente
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
2 191
-3.4%
11,52
25 240 USD
|
2 191
-3.4%
|
11,52
|
25 240 USD
|
|
|
2024-09-09 |
2024-09-09 |
VP
Vente planifiée
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
21 125
-5.5%
11,52
243 360 USD
|
21 125
-5.5%
|
11,52
|
243 360 USD
|
|
|
2024-09-09 |
2024-09-09 |
V
Vente
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
2 191
-2.0%
11,52
25 240 USD
|
2 191
-2.0%
|
11,52
|
25 240 USD
|
|
|
2024-09-09 |
2024-09-09 |
VP
Vente planifiée
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
4 387
-4.9%
11,52
50 538 USD
|
4 387
-4.9%
|
11,52
|
50 538 USD
|
|
|
2024-09-09 |
2024-09-09 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
2 490
-3.2%
11,52
28 685 USD
|
2 490
-3.2%
|
11,52
|
28 685 USD
|
|
|
2024-09-05 |
2024-09-04 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
514
-0.7%
9,51
4 888 USD
|
514
-0.7%
|
9,51
|
4 888 USD
|
|
|
2024-04-12 |
2024-04-11 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
54
-0.1%
6,74
364 USD
|
54
-0.1%
|
6,74
|
364 USD
|
|
|
2024-02-02 |
2024-02-01 |
VP
Vente planifiée
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
2 590
-3.1%
8,86
22 947 USD
|
2 590
-3.1%
|
8,86
|
22 947 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
2 174
-2.5%
8,53
18 548 USD
|
2 174
-2.5%
|
8,53
|
18 548 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
4 195
-4.0%
8,53
35 789 USD
|
4 195
-4.0%
|
8,53
|
35 789 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
3 818
-5.1%
8,53
32 573 USD
|
3 818
-5.1%
|
8,53
|
32 573 USD
|
|
|
2024-02-02 |
2024-02-01 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
2 590
-3.3%
8,86
22 947 USD
|
2 590
-3.3%
|
8,86
|
22 947 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
2 174
-2.7%
8,53
18 548 USD
|
2 174
-2.7%
|
8,53
|
18 548 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
2 820
-5.1%
8,53
24 058 USD
|
2 820
-5.1%
|
8,53
|
24 058 USD
|
|
|
2024-02-02 |
2024-02-01 |
VP
Vente planifiée
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
10 016
-2.8%
8,86
88 742 USD
|
10 016
-2.8%
|
8,86
|
88 742 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
9 106
-2.5%
8,53
77 693 USD
|
9 106
-2.5%
|
8,53
|
77 693 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Vente
|
Inrig Jula
CHIEF MEDICAL OFFICER
Dirigeant
|
2 174
-3.6%
8,53
18 547 USD
|
2 174
-3.6%
|
8,53
|
18 547 USD
|
|
|
2024-01-25 |
2024-01-23 |
VP
Vente planifiée
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Dirigeant
|
2 062
-3.3%
8,96
18 476 USD
|
2 062
-3.3%
|
8,96
|
18 476 USD
|
|
|
2024-01-25 |
2024-01-23 |
VP
Vente planifiée
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
7 873
-3.2%
8,96
70 542 USD
|
7 873
-3.2%
|
8,96
|
70 542 USD
|
|
|
2024-01-25 |
2024-01-23 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Dirigeant
|
2 062
-3.5%
8,96
18 476 USD
|
2 062
-3.5%
|
8,96
|
18 476 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Vente
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Dirigeant
|
853
-1.7%
9,07
7 735 USD
|
853
-1.7%
|
9,07
|
7 735 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Vente
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Dirigeant
|
1 559
-1.9%
9,07
14 138 USD
|
1 559
-1.9%
|
9,07
|
14 138 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Vente
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Dirigeant
|
910
-2.2%
9,07
8 252 USD
|
910
-2.2%
|
9,07
|
8 252 USD
|
|
|
2024-01-05 |
2024-01-04 |
VP
Vente planifiée
|
Inrig Jula
Chief Medical Officer
Dirigeant
|
440
-1.2%
9,17
4 035 USD
|
440
-1.2%
|
9,17
|
4 035 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
Inrig Jula
Chief Medical Officer
Dirigeant
|
2 069
-5.5%
9,48
19 613 USD
|
2 069
-5.5%
|
9,48
|
19 613 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Vente
|
Heerma Peter
Chief Commercial Officer
Dirigeant
|
3 091
-3.7%
8,25
25 504 USD
|
3 091
-3.7%
|
8,25
|
25 504 USD
|
|
|
2023-09-05 |
2023-09-05 |
VP
Vente planifiée
|
Dube Eric M
Chief Executive Officer
Administrateur exécutif
|
4 455
-1.8%
14,71
65 533 USD
|
4 455
-1.8%
|
14,71
|
65 533 USD
|
|
|
2023-09-05 |
2023-09-05 |
V
Vente
|
Cline Christopher R.
Chief Financial Officer
Dirigeant
|
457
-0.9%
14,71
6 723 USD
|
457
-0.9%
|
14,71
|
6 723 USD
|
|
|
2023-09-05 |
2023-09-05 |
VP
Vente planifiée
|
ROTE WILLIAM E.
Senior Vice President, R&D
Dirigeant
|
1 815
-2.9%
14,71
26 699 USD
|
1 815
-2.9%
|
14,71
|
26 699 USD
|
|
|
2023-09-05 |
2023-09-05 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & Corporate Secretary
Dirigeant
|
1 815
-3.0%
14,71
26 699 USD
|
1 815
-3.0%
|
14,71
|
26 699 USD
|
|
|
2023-05-12 |
2023-05-11 |
VP
Vente planifiée
|
Calvin Sandra
SVP, Chief Accounting Officer
Dirigeant
|
122
-0.3%
16,12
1 967 USD
|
122
-0.3%
|
16,12
|
1 967 USD
|
|
|
2023-05-12 |
2023-05-10 |
VP
Vente planifiée
|
ROTE WILLIAM E.
Senior Vice President, R&D
Dirigeant
|
825
-1.4%
16,59
13 687 USD
|
825
-1.4%
|
16,59
|
13 687 USD
|
|
|
2023-05-12 |
2023-05-10 |
V
Vente
|
Cline Christopher R.
Chief Financial Officer
Dirigeant
|
455
-0.9%
16,59
7 548 USD
|
455
-0.9%
|
16,59
|
7 548 USD
|
|
|
2023-05-12 |
2023-05-10 |
VP
Vente planifiée
|
REED ELIZABETH E
SVP, GC & Corporate Secretary
Dirigeant
|
825
-1.4%
16,59
13 687 USD
|
825
-1.4%
|
16,59
|
13 687 USD
|
|
|
2023-05-12 |
2023-05-10 |
V
Vente
|
Calvin Sandra
SVP, Chief Accounting Officer
Dirigeant
|
436
-1.0%
16,59
7 233 USD
|
436
-1.0%
|
16,59
|
7 233 USD
|
|
|
2023-04-13 |
2023-04-11 |
V
Vente
|
Cline Christopher R.
Chief Financial Officer
Dirigeant
|
47
-0.1%
21,49
1 010 USD
|
47
-0.1%
|
21,49
|
1 010 USD
|
|
|
2023-02-02 |
2023-02-02 |
VP
Vente planifiée
|
Calvin Sandra
SVP, Chief Accounting Officer
Dirigeant
|
360
-0.8%
22,42
8 071 USD
|
360
-0.8%
|
22,42
|
8 071 USD
|
|
|
2023-02-02 |
2023-02-01 |
VP
Vente planifiée
|
Dube Eric M
Chief Executive Officer
Administrateur exécutif
|
8 196
-3.3%
22,25
182 361 USD
|
8 196
-3.3%
|
22,25
|
182 361 USD
|
|
